The Magnitude of the Secondary B Cell Response is Shaped by Pre‐Existing Antibodies Rather Than the Number of Memory B Cells Present
European Journal of Immunology · 2026-11 · 56 (11)
DOI: 10.1002/eji.70315 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 11.11.2026. Verfasst von Malte J Hoormann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Cellular Technology Ltd. (CTL), Shaker Heights, Ohio, USA. Hauptthemen laut MEDLINE: Memory B Cells, Antibodies, Viral, SARS-CoV-2, Immunologic Memory. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: R&D budget of Cellular Technology Limited.
Abstract (Originalsprache)
Clonal expansion of memory lymphocytes after each antigen encounter is the primary mechanism for amplifying immunity. For most vaccines, boosters are common practice and are expected to stimulate proliferation of pre‐existing memory B cells (B mem ), thereby expanding the antigen‐specific B mem pool, along with driving their differentiation into antibody‐producing plasma cells that replenish antibody titers. It is widely assumed that the number of B mem present in the body prior to administration of a booster vaccination will define the magnitude of the ensuing response. By comparing B mem frequencies and antibody titers in the same individuals after primary and secondary vaccination with SARS‐CoV‐2 Spike (S‐antigen)‐encoding mRNA, we found that expansion of B mem and the relative increase of the secondary antibody response were not determined by the number of B mem measured before the second vaccine inoculation. Instead, both were inversely correlated with levels of S‐antigen‐specific serum IgG prior to the secondary antigen exposure. Collectively, these data suggest that secondary B cell responses are constrained by antibody feedback inhibition of B mem , rather than their scarcity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development, Cellular Technology Ltd. (CTL), Shaker Heights, Ohio, USA.
- University of Bonn and University Hospital Bonn, Institute of Neuroanatomy, Bonn, Germany.
- Contract Laboratory, CTL, Shaker Heights, Ohio, USA.
Förderung
- R&D budget of Cellular Technology Limited
Zitieren
APA
Hoormann, M. J., Becza, N., Yao, L., Gorbachev, A. V., Kuerten, S., Tary-Lehmann, M., Kirchenbaum, G. A., & Lehmann, P. V. (2026). The Magnitude of the Secondary B Cell Response is Shaped by Pre‐Existing Antibodies Rather Than the Number of Memory B Cells Present. European Journal of Immunology, 56(11). https://doi.org/10.1002/eji.70315
Vancouver
Hoormann MJ, Becza N, Yao L, Gorbachev AV, Kuerten S, Tary-Lehmann M, et al. The Magnitude of the Secondary B Cell Response is Shaped by Pre‐Existing Antibodies Rather Than the Number of Memory B Cells Present. European Journal of Immunology. 2026;56(11). doi:10.1002/eji.70315
BibTeX
@article{Hoormann2026,
author = {Hoormann, Malte J and Becza, Noémi and Yao, Lingling and Gorbachev, Anton V and Kuerten, Stefanie and Tary-Lehmann, Magdalena and Kirchenbaum, Greg A and Lehmann, Paul V},
title = {The Magnitude of the Secondary B Cell Response is Shaped by Pre‐Existing Antibodies Rather Than the Number of Memory B Cells Present},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {11},
doi = {10.1002/eji.70315}
}
EUVIMED